-
1
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
2
-
-
84856495152
-
Targeting IAP proteins for therapeutic intervention in cancer
-
Fulda S, Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov 2012; 11: 109-124.
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 109-124
-
-
Fulda, S.1
Vucic, D.2
-
3
-
-
44949240664
-
CIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
-
Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008; 30: 689-700.
-
(2008)
Mol Cell
, vol.30
, pp. 689-700
-
-
Bertrand, M.J.1
Milutinovic, S.2
Dickson, K.M.3
Ho, W.C.4
Boudreault, A.5
Durkin, J.6
-
4
-
-
38849199203
-
Shared principles in NF-kappaB signaling
-
Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344-362.
-
(2008)
Cell
, vol.132
, pp. 344-362
-
-
Hayden, M.S.1
Ghosh, S.2
-
5
-
-
56349164239
-
Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
-
Zarnegar BJ, Wang Y, Mahoney DJ, Dempsey PW, Cheung HH, He J et al. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol 2008; 9: 1371-1378.
-
(2008)
Nat Immunol
, vol.9
, pp. 1371-1378
-
-
Zarnegar, B.J.1
Wang, Y.2
Mahoney, D.J.3
Dempsey, P.W.4
Cheung, H.H.5
He, J.6
-
6
-
-
36048999753
-
IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis
-
Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131: 669-681.
-
(2007)
Cell
, vol.131
, pp. 669-681
-
-
Varfolomeev, E.1
Blankenship, J.W.2
Wayson, S.M.3
Fedorova, A.V.4
Kayagaki, N.5
Garg, P.6
-
7
-
-
36148954336
-
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis
-
Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131: 682-693.
-
(2007)
Cell
, vol.131
, pp. 682-693
-
-
Vince, J.E.1
Wong, W.W.2
Khan, N.3
Feltham, R.4
Chau, D.5
Ahmed, A.U.6
-
8
-
-
77449101221
-
Regulation of immunity and oncogenesis by the IRF transcription factor family
-
Savitsky D, Tamura T, Yanai H, Taniguchi T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 2010; 59: 489-510.
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 489-510
-
-
Savitsky, D.1
Tamura, T.2
Yanai, H.3
Taniguchi, T.4
-
9
-
-
0023788435
-
Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements
-
Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 1988; 54: 903-913.
-
(1988)
Cell
, vol.54
, pp. 903-913
-
-
Miyamoto, M.1
Fujita, T.2
Kimura, Y.3
Maruyama, M.4
Harada, H.5
Sudo, Y.6
-
10
-
-
0034019810
-
Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. the C-terminal region governs the protein stability
-
Nakagawa K, Yokosawa H. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability. Eur J Biochem/FEBS 2000; 267: 1680-1686.
-
(2000)
Eur J Biochem/FEBS
, vol.267
, pp. 1680-1686
-
-
Nakagawa, K.1
Yokosawa, H.2
-
11
-
-
53549089344
-
CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1
-
Moschonas A, Kouraki M, Knox PG, Thymiakou E, Kardassis D, Eliopoulos AG. CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1. Mol Cell Biol 2008; 28: 6208-6222.
-
(2008)
Mol Cell Biol
, vol.28
, pp. 6208-6222
-
-
Moschonas, A.1
Kouraki, M.2
Knox, P.G.3
Thymiakou, E.4
Kardassis, D.5
Eliopoulos, A.G.6
-
12
-
-
36849027823
-
EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells
-
Andersen P, Pedersen MW, Woetmann A, Villingshoj M, Stockhausen MT, Odum N et al. EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells. Int J Cancer 2008; 122: 342-349.
-
(2008)
Int J Cancer
, vol.122
, pp. 342-349
-
-
Andersen, P.1
Pedersen, M.W.2
Woetmann, A.3
Villingshoj, M.4
Stockhausen, M.T.5
Odum, N.6
-
13
-
-
0031570834
-
Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages
-
Lehtonen A, Matikainen S, Julkunen I. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol 1997; 159: 794-803.
-
(1997)
J Immunol
, vol.159
, pp. 794-803
-
-
Lehtonen, A.1
Matikainen, S.2
Julkunen, I.3
-
15
-
-
0037038696
-
Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway
-
Pamment J, Ramsay E, Kelleher M, Dornan D, Ball KL. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 2002; 21: 7776-7785.
-
(2002)
Oncogene
, vol.21
, pp. 7776-7785
-
-
Pamment, J.1
Ramsay, E.2
Kelleher, M.3
Dornan, D.4
Ball, K.L.5
-
16
-
-
24344507725
-
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis
-
Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, Zwart A et al. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 2005; 26: 1527-1535.
-
(2005)
Carcinogenesis
, vol.26
, pp. 1527-1535
-
-
Bouker, K.B.1
Skaar, T.C.2
Riggins, R.B.3
Harburger, D.S.4
Fernandez, D.R.5
Zwart, A.6
-
17
-
-
4143116932
-
Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL
-
Clarke N, Jimenez-Lara AM, Voltz E, Gronemeyer H. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J 2004; 23: 3051-3060.
-
(2004)
EMBO J
, vol.23
, pp. 3051-3060
-
-
Clarke, N.1
Jimenez-Lara, A.M.2
Voltz, E.3
Gronemeyer, H.4
-
18
-
-
77949539947
-
IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells
-
Gao J, Senthil M, Ren B, Yan J, Xing Q, Yu J et al. IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells. Cell Death Differ 2010; 17: 699-709.
-
(2010)
Cell Death Differ
, vol.17
, pp. 699-709
-
-
Gao, J.1
Senthil, M.2
Ren, B.3
Yan, J.4
Xing, Q.5
Yu, J.6
-
19
-
-
49149119083
-
Interferon regulatory factor-1 (IRF-1) regulates VEGF-induced angiogenesis in HUVECs
-
Lee JH, Chun T, Park SY, Rho SB. Interferon regulatory factor-1 (IRF-1) regulates VEGF-induced angiogenesis in HUVECs. Biochim Biophys Acta 2008; 1783: 1654-1662.
-
(2008)
Biochim Biophys Acta
, vol.1783
, pp. 1654-1662
-
-
Lee, J.H.1
Chun, T.2
Park, S.Y.3
Rho, S.B.4
-
20
-
-
28944440894
-
IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS
-
Kollet JI, Petro TM. IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol Immunol 2006; 43: 623-633.
-
(2006)
Mol Immunol
, vol.43
, pp. 623-633
-
-
Kollet, J.I.1
Petro, T.M.2
-
21
-
-
41149122048
-
IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer
-
Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E et al. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J Virol 2008; 82: 3632-3641.
-
(2008)
J Virol
, vol.82
, pp. 3632-3641
-
-
Sgarbanti, M.1
Remoli, A.L.2
Marsili, G.3
Ridolfi, B.4
Borsetti, A.5
Perrotti, E.6
-
22
-
-
84874763808
-
Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1-and NF-kappaB-dependent manner
-
Wagner L, Marschall V, Karl S, Cristofanon S, Zobel K, Deshayes K et al. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1-and NF-kappaB-dependent manner. Oncogene 2013; 32: 988-997.
-
(2013)
Oncogene
, vol.32
, pp. 988-997
-
-
Wagner, L.1
Marschall, V.2
Karl, S.3
Cristofanon, S.4
Zobel, K.5
Deshayes, K.6
-
23
-
-
84855440150
-
Requirement of nuclear factor kappaB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis
-
Stadel D, Cristofanon S, Abhari BA, Deshayes K, Zobel K, Vucic D et al. Requirement of nuclear factor kappaB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis. Neoplasia 2011; 13: 1162-1170.
-
(2011)
Neoplasia
, vol.13
, pp. 1162-1170
-
-
Stadel, D.1
Cristofanon, S.2
Abhari, B.A.3
Deshayes, K.4
Zobel, K.5
Vucic, D.6
-
24
-
-
80053933840
-
NF-{kappa}B is required for smac mimetic-mediated sensitization of glioblastoma cells for {gamma}-irradiation-induced apoptosis
-
Berger R, Jennewein C, Marschall V, Karl S, Cristofanon S, Wagner L et al. NF-{kappa}B is required for smac mimetic-mediated sensitization of glioblastoma cells for {gamma}-irradiation-induced apoptosis. Mol Cancer Ther 2011; 10: 1867-1875.
-
(2011)
Mol Cancer Ther
, pp. 10
-
-
Berger, R.1
Jennewein, C.2
Marschall, V.3
Karl, S.4
Cristofanon, S.5
Wagner, L.6
-
25
-
-
1442278664
-
IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo
-
Kim PK, Armstrong M, Liu Y, Yan P, Bucher B, Zuckerbraun BS et al. IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo. Oncogene 2004; 23: 1125-1135.
-
(2004)
Oncogene
, vol.23
, pp. 1125-1135
-
-
Kim, P.K.1
Armstrong, M.2
Liu, Y.3
Yan, P.4
Bucher, B.5
Zuckerbraun, B.S.6
-
26
-
-
84889560425
-
Identification of DR5 as a critical, NF-kappaB-regulated mediator of Smac-induced apoptosis
-
Eckhardt I, Roesler S, Fulda S. Identification of DR5 as a critical, NF-kappaB-regulated mediator of Smac-induced apoptosis. Cell Death Dis 2013; 4: e936.
-
(2013)
Cell Death Dis
, vol.4
, pp. e936
-
-
Eckhardt, I.1
Roesler, S.2
Fulda, S.3
-
27
-
-
84875877848
-
Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells
-
Tchoghandjian A, Jennewein C, Eckhardt I, Rajalingam K, Fulda S. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells. Cell Death Dis 2013; 4: e564.
-
(2013)
Cell Death Dis
, vol.4
, pp. e564
-
-
Tchoghandjian, A.1
Jennewein, C.2
Eckhardt, I.3
Rajalingam, K.4
Fulda, S.5
-
28
-
-
84898037741
-
Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB
-
Tchoghandjian A, Jennewein C, Eckhardt I, Momma S, Figarella-Branger D, Fulda S. Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB. Cell Death Differ 2014; 21: 735-747.
-
(2014)
Cell Death Differ
, vol.21
, pp. 735-747
-
-
Tchoghandjian, A.1
Jennewein, C.2
Eckhardt, I.3
Momma, S.4
Figarella-Branger, D.5
Fulda, S.6
-
29
-
-
77953919146
-
IRF5 is required for late-phase TNF secretion by human dendritic cells
-
Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova IA. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 2010; 115: 4421-4430.
-
(2010)
Blood
, vol.115
, pp. 4421-4430
-
-
Krausgruber, T.1
Saliba, D.2
Ryzhakov, G.3
Lanfrancotti, A.4
Blazek, K.5
Udalova, I.A.6
-
30
-
-
0030022331
-
Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach
-
Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y et al. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res 1996; 56: 612-615.
-
(1996)
Cancer Res
, vol.56
, pp. 612-615
-
-
Tamura, G.1
Ogasawara, S.2
Nishizuka, S.3
Sakata, K.4
Maesawa, C.5
Suzuki, Y.6
-
31
-
-
0027519370
-
Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: Retention of IRF1 on the 5q-chromosome in some patients with the 5q-syndrome
-
Boultwood J, Fidler C, Lewis S, MacCarthy A, Sheridan H, Kelly S et al. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q-chromosome in some patients with the 5q-syndrome. Blood 1993; 82: 2611-2616.
-
(1993)
Blood
, vol.82
, pp. 2611-2616
-
-
Boultwood, J.1
Fidler, C.2
Lewis, S.3
MacCarthy, A.4
Sheridan, H.5
Kelly, S.6
-
32
-
-
77951297779
-
Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer
-
Cavalli LR, Riggins RB, Wang A, Clarke R, Haddad BR. Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer. Breast Cancer Res Treat 2010; 121: 227-231.
-
(2010)
Breast Cancer Res Treat
, vol.121
, pp. 227-231
-
-
Cavalli, L.R.1
Riggins, R.B.2
Wang, A.3
Clarke, R.4
Haddad, B.R.5
-
33
-
-
0030031630
-
Common deleted region on the long arm of chromosome 5 in esophageal carcinoma
-
Ogasawara S, Tamura G, Maesawa C, Suzuki Y, Ishida K, Satoh N et al. Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroenterology 1996; 110: 52-57.
-
(1996)
Gastroenterology
, vol.110
, pp. 52-57
-
-
Ogasawara, S.1
Tamura, G.2
Maesawa, C.3
Suzuki, Y.4
Ishida, K.5
Satoh, N.6
-
34
-
-
58149300251
-
IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages
-
Vila-del Sol V, Punzon C, Fresno M. IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 2008; 181: 4461-4470.
-
(2008)
J Immunol
, vol.181
, pp. 4461-4470
-
-
Vila-Del Sol, V.1
Punzon, C.2
Fresno, M.3
-
35
-
-
51549118941
-
TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol
-
Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 2008; 181: 3049-3056.
-
(2008)
J Immunol
, vol.181
, pp. 3049-3056
-
-
Zhao, X.J.1
Dong, Q.2
Bindas, J.3
Piganelli, J.D.4
Magill, A.5
Reiser, J.6
-
36
-
-
84874087182
-
Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production
-
Kearney CJ, Sheridan C, Cullen SP, Tynan GA, Logue SE, Afonina IS et al. Inhibitor of apoptosis proteins (IAPs) and their antagonists regulate spontaneous and tumor necrosis factor (TNF)-induced proinflammatory cytokine and chemokine production. J Biol Chem 2013; 288: 4878-4890.
-
(2013)
J Biol Chem
, vol.288
, pp. 4878-4890
-
-
Kearney, C.J.1
Sheridan, C.2
Cullen, S.P.3
Tynan, G.A.4
Logue, S.E.5
Afonina, I.S.6
-
37
-
-
80054041125
-
IRF-1 expression is essential for natural killer cells to suppress metastasis
-
Ksienzyk A, Neumann B, Nandakumar R, Finsterbusch K, Grashoff M, Zawatzky R et al. IRF-1 expression is essential for natural killer cells to suppress metastasis. Cancer Res 2011; 71: 6410-6418.
-
(2011)
Cancer Res
, vol.71
, pp. 6410-6418
-
-
Ksienzyk, A.1
Neumann, B.2
Nandakumar, R.3
Finsterbusch, K.4
Grashoff, M.5
Zawatzky, R.6
-
38
-
-
84858163320
-
Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy
-
Emeagi PU, Van Lint S, Goyvaerts C, Maenhout S, Cauwels A, McNeish IA et al. Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy. Cancer Res 2012; 72: 1342-1352.
-
(2012)
Cancer Res
, vol.72
, pp. 1342-1352
-
-
Emeagi, P.U.1
Van Lint, S.2
Goyvaerts, C.3
Maenhout, S.4
Cauwels, A.5
McNeish, I.A.6
-
39
-
-
55549115035
-
Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-alpha and PGE2
-
Hu Y, Park-Min KH, Yarilina A, Ivashkiv LB. Regulation of STAT pathways and IRF1 during human dendritic cell maturation by TNF-alpha and PGE2. J Leukoc Biol 2008; 84: 1353-1360.
-
(2008)
J Leukoc Biol
, vol.84
, pp. 1353-1360
-
-
Hu, Y.1
Park-Min, K.H.2
Yarilina, A.3
Ivashkiv, L.B.4
-
40
-
-
84872460484
-
DNA-binding regulates site-specific ubiquitination of IRF-1
-
Landre V, Pion E, Narayan V, Xirodimas DP, Ball KL. DNA-binding regulates site-specific ubiquitination of IRF-1. Biochem J 2013; 449: 707-717.
-
(2013)
Biochem J
, vol.449
, pp. 707-717
-
-
Landre, V.1
Pion, E.2
Narayan, V.3
Xirodimas, D.P.4
Ball, K.L.5
-
41
-
-
65549151902
-
IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells
-
Shen Y, Xia M, Zhang J, Xu L, Yang J, Chen A et al. IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells. Mol Immunol 2009; 46: 2045-2053.
-
(2009)
Mol Immunol
, vol.46
, pp. 2045-2053
-
-
Shen, Y.1
Xia, M.2
Zhang, J.3
Xu, L.4
Yang, J.5
Chen, A.6
-
43
-
-
77449136821
-
Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response
-
Karl S, Pritschow Y, Volcic M, Hacker S, Baumann B, Wiesmuller L et al. Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response. J Cell Mol Med 2009; 13: 4239-4256.
-
(2009)
J Cell Mol Med
, vol.13
, pp. 4239-4256
-
-
Karl, S.1
Pritschow, Y.2
Volcic, M.3
Hacker, S.4
Baumann, B.5
Wiesmuller, L.6
-
44
-
-
0030815250
-
Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors
-
Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M et al. Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 1997; 57: 4956-4964.
-
(1997)
Cancer Res
, vol.57
, pp. 4956-4964
-
-
Fulda, S.1
Friesen, C.2
Los, M.3
Scaffidi, C.4
Mier, W.5
Benedict, M.6
-
45
-
-
33846222280
-
Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells
-
Vogler M, Durr K, Jovanovic M, Debatin KM, Fulda S. Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells. Oncogene 2007; 26: 248-257.
-
(2007)
Oncogene
, vol.26
, pp. 248-257
-
-
Vogler, M.1
Durr, K.2
Jovanovic, M.3
Debatin, K.M.4
Fulda, S.5
-
46
-
-
27144547145
-
Betulinic acid as new activator of NF-kappaB: Molecular mechanisms and implications for cancer therapy
-
Kasperczyk H, La Ferla-Brühl K, Westhoff MA, Behrend L, Zwacka RM, Debatin KM et al. Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene 2005; 24: 6945-6956.
-
(2005)
Oncogene
, vol.24
, pp. 6945-6956
-
-
Kasperczyk, H.1
La Ferla-Brühl, K.2
Westhoff, M.A.3
Behrend, L.4
Zwacka, R.M.5
Debatin, K.M.6
|